Skip to Content

Tag: biosensor


Also Noted

Biolinq’s multi-function biosensor receives FDA De Novo Classification 

September 30, 2025HME News Staff

SAN DIEGO – Biolinq has received De Novo Classification from the U.S. Food and Drug Administration for its lead product, Biolinq Shine, a patch on the forearm that provides real-time glucose feedback through a primary color-coded LED display, visible with or without a phone. The device provides additional insights, such as activity and sleep trends, through a mobile app. The company says Biolinq Shine, initially marketed to people with Type 2 diabetes, is the first wearable biosensor integrating...

Biolinq, Biolinq Shine, biosensor, Continuous Glucose Monitor (CGM), wearable


Read Full Articlered right arrow icon

Also Noted

Biosensor tech company secures $100M investment

April 22, 2025HME News Staff

SAN DIEGO – Biolinq, a healthcare technology company of biosensors, has received a $100 million Series C financing led by Alpha Wave Ventures, with participation from existing investors RiverVest Venture Partners, AXA IM Alts, LifeSci Venture Partners, M Ventures, Hikma Ventures, Aphelion Capital, Taisho Pharmaceutical and Features Capital. The funding will support Biolinq through the US regulatory approval process as the company prepares to bring the first autonomous intradermal glucose sensor...

Biolinq, biosensor, Glucose monitoring, wearables


Read Full Articlered right arrow icon